Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

198.48 USD +7.71 (+4.04%)
Official Closing Price Updated: 7:49 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,729,051
Open 196.00
Bid (Size) 198.00 (1)
Ask (Size) 199.69 (2)
Prev. Close 190.77
Today's Range 194.07 - 199.52
52wk Range 117.06 - 199.52
Shares Outstanding 1,085,430,420
Dividend Yield 1.13%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology company developing multi-specific antibodies,... 
From PR Newswire
Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement
Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021. Lilly will also conduct a conference call on that day with the... 
From PR Newswire

Performance

YTD
+19.93%
+19.93%
1 Month
+17.60%
+17.60%
3 Month
+38.99%
+38.99%
6 Month
+18.82%
+18.82%
1 Year
+40.86%
+40.86%

More News

Read More
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
From PR Newswire
Gabrielle Sulzberger Elected to Lilly Board of Directors
From PR Newswire
Lilly Awash In Catalysts, Pipeline Updates, Mizuho Says In Upgrade
Tags Analyst Ratings Analyst Color Vamil Divan
From Benzinga
Are These The Best Biotech Stocks To Buy This Month?
Tags Market News
From Stockmarket.com
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
From PR Newswire
Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today
Tags Trading Ideas M&A Health Care
From Benzinga
Eli Lilly rockets 14% after experimental Alzheimer's drug slows rate of decline in trial (LLY)
From Business Insider
High-tech British firms eye U.S. listings in blow to post-Brexit London stock market
Tags COMP UK:PRSM LLY
From MarketWatch
Notable Friday Option Activity: LLY, CTRN, NSTG
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.